title: [Clinical implication of a novel biomarker Ngal in CKD].
abstract: We review diagnostic importance of neutrophil gelatinase-associated lipocalin (Ngal or lipocalin 2) in acute kidney injury and chronic kidney disease, and discuss the impact of novel biomarker analysis upon progress of nephrology.
authors.affiliation: Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine.
authors.forename: Kiyoshi
authors.initials: K
authors.lastname: Mori
authors.forename: Masashi
authors.initials: M
authors.lastname: Mukoyama
authors.forename: Takashige
authors.initials: T
authors.lastname: Kuwabara
authors.forename: Masato
authors.initials: M
authors.lastname: Kasahara
authors.forename: Hideki
authors.initials: H
authors.lastname: Yokoi
authors.forename: Kazuwa
authors.initials: K
authors.lastname: Nakao
mesh_terms: D058186:Acute Kidney Injury / Q000175:diagnosis*; D000209:Acute-Phase Proteins / Q000652:urine*; D000818:Animals; D015415:Biomarkers / Q000652:urine*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis*; D000071068:Lipocalin-2; D054834:Lipocalins / Q000652:urine*; D011518:Proto-Oncogene Proteins / Q000652:urine*
chemical_list: D000209:Acute-Phase Proteins; D015415:Biomarkers; C489506:LCN2 protein, human; D000071068:Lipocalin-2; D054834:Lipocalins; D011518:Proto-Oncogene Proteins